The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...
We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...
Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needs AI-driven development strategy designed to significantly ...
Spread the loveThe landscape of sustainable food production has taken a significant leap forward with the FDA’s recent approval of All G’s lab-grown lactoferrin protein. This groundbreaking decision ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
When GSK’s new CEO Luke Miels told investors last month that “smart business development” is a key pillar for his strategy, he wasn’t lying. The British Big Pharma has just announced its second ...
What’s new in biotech and pharma? Over the last couple of weeks, we’ve seen the unveiling of a spatial assay for visualizing functional protein–protein interactions, an energy dispersive X-ray ...
19don MSN
Seattle’s biotech scene is world-class — Life Science Washington is teaching it how to brag
Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.
The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...
India Education Diary (English) on MSN
Monash research drives launch of new biotech targeting genetic kidney disease
India, April 4 -- Monash University researchers are advancing a new therapeutic approach for Autosomal Dominant Polycystic Kidney Disease (ADPKD) through biotechnology company xCystence Bio, supported ...
Forbes contributors publish independent expert analyses and insights. I write about finance, innovation, climate and sustainability Europe’s next wave of biotech innovation could determine how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results